glp 3 vs retatrutide peptide for weight loss and fat burning Retatrutide vs Tirzepatide: 24% vs

So what do these new contenders mean for food and beverage

The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes

DOI: (en ingls) 68 (4): 954-1013

Liraglutide results in two placebo-controlled studies were similar with a systolic BP change of 5.6 mmHg (95% CI 5.8, 5.4) and diastolic BP change of 4.5 mmHg (95% CI 4.7, 4.3)

This triggers a cascade of responses including increased insulin release, decreased glucagon secretion, slowed stomach emptying, and reduced appetite

The two drugs are also competing head to head in obesity, where Novo Nordisk sells its drug as Wegovy and Lilly's is called Zepbound